Unibio’s renewed mission and branding signals a new chapter in the journey to transform sustainable protein production
Unibio becomes a member of the LCA institute
CEO David Henstrom talks to Proactive Investor about our pioneeering venture in alternative protein
Katie Pilbeam, Presenter from Proactive Investor in London interviewed David Henstrom on 20 January about Unibio’s alternative sustainable protein and our journey towards its production on an industrial scale. Watch their video recording to hear about our technology and the process which mimics a natural one:
Søren Olsen joins the team
We are delighted that Søren Olsen will be joining us as our new Chief Business Officer (CBO) on 1 December. He will take the lead on building our network of Joint Ventures and licensees for Unibio’s U-Loop® technology across the globe. This technology is a unique, first to be commercially scaled, fermentation process developed to produce a sustainable protein from natural gas or biogas.
Søren comes to us from Haldo Topsoe where he was Director for Strategic Alliances. He is a civil engineer with a specialty in chemistry and holds a business diploma in foreign trade.
Unibio makes its first ever commercial shipment of Uniprotein® in Europe to Danish Agro
- The first ever shipment of Uniprotein® to a European based customer has been made to Danish Agro, the international agribusiness group
- Uniprotein® is a hiqh-quality, sustainable protein that is made from the microbial fermentation of natural gases, including biogas
- Danish Agro announces that Uniprotein® has proved to be very suitable for piglet feed and will be included in Danish Agro’s feed mixtures as a supplement to protein from potato flour and fishmeal from 15 October 2021
Copenhagen, 6th October 2021 – Unibio, the sustainable protein company, today announced that an initial shipment of 24 tonnes of its groundbreaking Uniprotein® product has been made to Danish Agro, the international agribusiness group, its first commercial customer in Europe. Unibio will deliver Uniprotein® to Danish Agro at an ongoing basis to be a part of Danish Agro’s feed mixtures.
Unibio has developed an innovative continuous-flow microbial fermentation process that uses its proprietary U-Loop® technology and natural gases, including biogas, as the primary feedstock. Uniprotein® is differentiated through its high quality, allowing it to replace products such as fish meal, protein from potato flour, and concentrated soy in feed for fish and animals, such as pigs. The majority of fishmeal is unsustainably sourced, threatens biodiversity and ocean ecosystems. Similarly, global demand for soya threatens further rainforest deforestation and wider habitat destruction. Unibio’s technology enables production of more sustainable protein in very large and scalable volumes to help meet the world’s growing protein needs.
David Henstrom, Chief Executive Officer said: “The shipment of our first commercial order within Europe is an important milestone for Unibio. We have put a lot of hard work into the development of our U-Loop® fermentation technology over the last decade and our Uniprotein® product has now been tested by international compound feed companies with a resoundingly positive response. This is the first time that any single-cell protein has been used as a key ingredient in Danish Agro’s pig feed. We look forward to continuing our collaboration with Danish Agro and increasing our industrial production of sustainable protein to meet the increasing global demand we see.”
Arne Ringsing, Product Manager, Swine, Danish Agro said: “We have been actively looking for a supplement to the conventional protein used in animal feed. We have tested Uniprotein® and it has been shown to be very suitable for piglet feed and will be included in the feed mixtures as a supplement to protein from potato flour and fishmeal from 15 October. We are happy to now be able to use Uniprotein® because it will benefit both the farmers’ pig herds and the environment. There is an ever-growing demand for sustainable protein and Uniprotein® can play an important part in meeting that need.”
US$15m financing round completed – Upsized following significant demand
Copenhagen, 29 June- Unibio, the sustainable protein company, today announced the successful completion of a US$15m bridge round financing, predominantly from existing shareholders. The bridge round, arranged by West Hill Capital, was increased due to significant investor demand and was 2.2x oversubscribed. The valuation of Unibio is now above US$300m. The capital raised will be used for general corporate purposes and to support the company’s future development plans.
Unibio has also successfully closed the previously announced partnership agreement with Stafilies in respect of Protelux, the first industrial-scale plant producing Uniprotein®. As part of the transaction, the intellectual property and experience gained by Protelux in constructing and operating the world’s first industrial-scale U-Loop® fermenter will be shared with Unibio and can be leveraged when designing and building similar facilities around the world. Following the partnership, Stafilies is now a significant shareholder in Unibio.
David Henstrom, the new Chief Executive Officer, who joined Unibio from Cargill has also now taken up his role to grow Unibio.
Jan Boeg Hansen, Chairman, said:
“It has been an extremely busy and successful year for Unibio, with the commencement of industrial production and the completion of the capital raising. The confidence placed in us by our shareholders is testimony to the strong story that Unibio has to tell and now that David has joined us we are working hard to continue the development of Unibio at a high pace.”
Unibio Appoints New CEO To Drive Next Stage of Growth - David Henstrom joins from Cargill
Copenhagen 17 May 2021, Unibio, the sustainable protein company, today announces that it has appointed David Henstrom as its new CEO. He is expected to join the company in June 2021. This follows the decision of Henrik Busch-Larsen, the current CEO and member of the founding family, to step down from his role to pursue other business interests. Henrik will continue to serve as a board member of the company and remains one of its major shareholders
.David joins from Cargill, the global food and nourishment giant, where he has worked since 1994 across a range of business units, most recently as Vice President and Managing Director for Growth Ventures and Commercial Excellence at the Salt Group. His long track record across Cargill’s food and nutrition businesses includes leading the formation of a joint venture with PURIS Proteins which enabled Cargill’s entry into the pea protein business.
Jan Boeg Hansen, Chair of the Board, said: “Henrik has been the driving force behind Unibio for more than a decade, and we owe him an immense debt of gratitude; we simply would not be here without him. I am delighted that Henrik will continue to stay involved with the company. I would also like to welcome David to the team. He has an exemplary track record of driving highly specialized food and nutrition businesses across Cargill’s portfolio worldwide, and his skills and experience will be invaluable as we continue the global rollout of mass production of Uniprotein®, our leading sustainable protein.”
Henrik Busch-Larsen, outgoing CEO, said: “We have arrived at a natural point in Unibio’s development where a range of different skills are needed to take the company to the next stage. David has an incredible track record that complements Unibio’s future development areas very well and I am excited to see where he will take Unibio in the coming years.”
David Henstrom, the incoming CEO, said: “Unibio is uniquely positioned, with a sustainable protein that can be produced at an industrial scale, adding value to feed markets worldwide. They have license or production agreements with partners in three continents. I look forward to helping accelerate their expansion in the years ahead.”
For media enquiries / access to photos, please contact
Unibio
Trine Leth, Head of Communications/Kommunikationsdirektør
T: +45 23231965 / E: tl@unibiogroup.com